Skip to main content
Log in

Frühe fetale Echokardiographie

Early fetal echocardiography

  • Zum Thema
  • Published:
Der Gynäkologe Aims and scope

Zusammenfassung

Die frühe fetale Echokardiographie erfordert besondere Kenntnisse der fetalen Herzanatomie, der technischen Limitationen und im Bereich der Transvaginalsonographie. Kongenitale Herzfehler gehören zu den häufigsten angeborenen schweren Fehlbildungen. Die klassischen Indikationen zur fetalen Echokardiographie werden in der frühen Schwangerschaft durch den Nachweis einer verdickten Nackentransparenz ergänzt. Eine verdickte Nackentransparenz ist mit einem höheren Risiko für Herzdefekte assoziiert. Allerdings weisen nur 10–20% der schwereren Herzfehler eine verdickte Nackentransparenz auf, sodass die Entdeckungsraten für Herzfehler weit niedriger liegen als bei der detaillierten Darstellung des Vierkammerblicks im 2. Trimenon und der Kombination von Vierkammerblick- und Ausflusstraktdarstellung im 2. Trimenon. Doppleruntersuchungen des Ductus venosus zwischen der 11. und 14. SSW könnten zusätzlich hilfreich sein. Da strukturelle Anomalien des fetalen Herzens und der großen Gefäße sich erst später im Verlauf der Schwangerschaft manifestieren können, ist auch bei Darstellung einer normalen kardialen Anatomie und normaler Blutflussmuster im Rahmen der frühen Echokardiographie eine weitere Echokardiographie um die 20. SSW erforderlich.

Abstract

The development of high-resolution ultrasound machines with high-frequency transvaginal and transabdominal probes as well as use of color Doppler echocardiography have made it possible to evaluate fetal heart status in detail as early as the end of the first trimester and beginning of the second trimester of pregnancy. Early fetal echocardiography not only requires extensive knowledge of early fetal cardiac anatomy and awareness of technical limitations, but also expertise in the field of transvaginal sonography. These prerequisites are usually only met in specialized centers so that its use is limited to groups at risk of congenital heart abnormalities. The prevalence of congenital heart defects is 5–8 per 1000 live births, making them the most frequent of severe congenital malformations. Because of the high lethality in fetuses with severe deformities, especially chromosomal aberrations and cardiac defects, prevalence during the first trimester is likely to be 15–20 per 1000 fetuses. The classic indications for fetal echocardiography are supplemented by evidence of increased nuchal translucency in early pregnancy since measurement of nuchal translucency between the 11th and 14th week of gestation serves to identify fetuses not only at increased risk of chromosomal anomalies but also of congenital heart defects. The prevalence of defects increases in tandem with nuchal thickness. Increased nuchal translucency thickness is associated with a higher risk of heart defects than many other established indications for echocardiography. Admittedly, however, only 10–20% of severe cardiac defects exhibit increased nuchal translucency during early pregnancy so that the detection rates for cardiac defects are much lower than with a detailed four-chamber view on imaging during the second trimester (40%) and the combination of four-chamber view and imaging of the outflow tract in the second trimester (70%). Doppler examination of the ductus venosus between the 11th and 14th week of gestation can provide additional information since an association between abnormal blood flow patterns in the ductus venosus and cardiac defects in fetuses with increased nuchal translucency and normal karyotype has been described. Since structural anomalies of the fetal heart and the large vessels only become manifest in the later course of pregnancy, even when imaging evidences normal cardiac anatomy and normal blood flow pattern, a further echocardiographic examination is necessary around the 20th week of gestation, as is the case in all indications for echocardiography.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6

Literatur

  1. Achiron R, Tadmor O, Mashiach S (1991) Heart rate as a predictor of first-trimester spontaneous abortion after ultrasound-proven viability. Obstet Gynecol 78:330–334

    CAS  PubMed  Google Scholar 

  2. Achiron R, Rotstein Z, Lipitz S et al. (1994) First-trimester diagnosis of fetal congenital heart disease by transvaginal ultrasonography. Obstet Gynecol 84:69–72

    CAS  PubMed  Google Scholar 

  3. Achiron R, Weissman A, Rotstein Z et al. (1994) Transvaginal echocardiographic examination of the fetal heart between 13 and 15 weeks gestation in a low-risk population. J Ultrasound Med 13:783–789

    CAS  PubMed  Google Scholar 

  4. Allan L, Sharland G, Chita S et al. (1991) Chromosomal anomalies in fetal congenital heart disease. Ultrasound Obstet Gynecol 1:8–11

    Article  CAS  PubMed  Google Scholar 

  5. Baschat A, Gembruch U, Knöpfle G, Hansmann M (1999) First-trimester fetal heart block: a marker for cardiac anomaly. Ultrasound Obstet Gynecol 14:311–314

    Article  CAS  PubMed  Google Scholar 

  6. Berg C, Geipel A, Smrcek J et al. (2003) Prenatal diagnosis of cardiosplenic syndromes: a 10-year experience. Ultrasound Obstet Gynecol 22:451–459

    Article  CAS  PubMed  Google Scholar 

  7. Bilardo C, Müller M, Zikulnig L et al. (2001) Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstet Gynecol 17:288–294

    Article  CAS  PubMed  Google Scholar 

  8. Blaas H, Eik-Nes S, Kiserud T, Hellvik L (1995) Early development of the abdominal wall, stomach and heart from 7 to 12 weeks of gestation: a longitudinal ultrasound study. Ultrasound Obstet Gynecol 6:240–249

    Article  CAS  PubMed  Google Scholar 

  9. Bonnet D, Coltri A, Butera G (1999) Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 23:916–918

    Google Scholar 

  10. Boughman J, Neil C, Ferencz C, Loffredo C (1993) The genetics of congenital heart disease. In: Ferencz C, Rubin J, Loffredo C, Magee C (eds) Epidemiology of congenital heart disease. The Baltimore-Washington Infant Study 1981. Perspect Pediatr Cardiol 4:123–167

    Google Scholar 

  11. Boudjemline Y, Fermont L, Le Bidois J et al. (2001) Prevalence of 22q11 deletion in fetuses with conotruncal cardiac defects: a 6-year prospective study. J Pediatr 138:520–524

    Article  CAS  PubMed  Google Scholar 

  12. Bronshtein M, Siegler E, Eshcoli Z, Zimmer EZ (1992) Transvaginal ultrasound measurements of the fetal heart at 11 to 17 weeks of gestation. Am J Perinatol 9:38–42

    CAS  PubMed  Google Scholar 

  13. Bronshtein M, Zimmer E, Gerlis L et al. (1993) Early ultrasound diagnosis of fetal congenital heart defects in high-risk and low-risk pregnancies. Obstet Gynecol 82:225–229

    CAS  PubMed  Google Scholar 

  14. Buskens E, Steyerberg E, Hess J (1997) Routine prenatal screening for congenital heart disease: what can be expected? A decision-analytic approach. Am J Public Health 87:962–967

    CAS  PubMed  Google Scholar 

  15. Carvalho J, Moscoso G, Ville Y (1998) First-trimester transabdominal fetal echocardiography. Lancet 351:1023–1027

    Article  CAS  PubMed  Google Scholar 

  16. Chaoui R, Gembruch U (1997) Zur Epidemiologie der kongenitalen Herzfehler beim Feten und Neugeborenen. Gynäkologe 30:165–169

    Google Scholar 

  17. Chaoui R, Körner H, Bommer C et al. (1999) Pränatale Diagnostik von Herzfehlern und assoziierte chromosomale Aberrationen. Ultraschall Med 20:177–184

    Article  CAS  PubMed  Google Scholar 

  18. Chinn A, Fitzsimmons J, Shepard T, Fantel A (1989) Congenital heart disease among spontaneous abortuses and stillborn fetuses: prevalence and associations. Teratology 40:477–482

    Google Scholar 

  19. Copel J, Cullen M, Green J et al. (1988) The frequency of aneuploidy in prenatally diagnosed congenital heart disease: an indication for fetal karyotyping. Am J Obstet Gynecol 158:409–413

    CAS  PubMed  Google Scholar 

  20. Devine P, Simpson L (2000) Nuchal translucency and its relationship to congenital heart disease. Semin Perinatol 24:343–351

    CAS  PubMed  Google Scholar 

  21. Dolkart L, Reimers F (1991) Transvaginal fetal echocardiography in early pregnancy: normative data. Am J Obstet Gynecol 165:688–691

    CAS  PubMed  Google Scholar 

  22. Driscoll D (1994) Genetic basis of DiGeorge and velocardiofacial syndromes. Curr Opin Pediatr 6:702–706

    CAS  PubMed  Google Scholar 

  23. Favre R, Cherif Y, Kohler M, Kohler A et al. (2003) The role of fetal nuchal translucency and ductus venosus Doppler at 11–14 weeks of gestation in the detection of major congenital heart defects. Ultrasound Obstet Gynecol 21:239–243

    Article  CAS  PubMed  Google Scholar 

  24. Ferencz C, Neill C, Boughman J et al. (1989) Congenital cardiovascular malformations associated with chromosome abnormalities: an epidemiologic study. J Pediatr 114:79–86

    CAS  PubMed  Google Scholar 

  25. Ferencz C, Rubin J, Loffredo C, Magee C (1993) Epidemiology of congenital heart disease: the Baltimore-Washington-Infant-Study 1981–1989. Futura, Mount Kisco, NY

    Google Scholar 

  26. Gembruch U, Knöpfle G, Chatterjee M et al. (1990) First trimester diagnosis of fetal congenital heart disease by transvaginal two-dimensional and Doppler echocardiography. Obstet Gynecol 75:496–498

    CAS  PubMed  Google Scholar 

  27. Gembruch U, Knöpfle G, Bald R, Hansmann M (1993) Early diagnosis of fetal congenital heart disease by transvaginal echocardiography. Ultrasound Obstet Gynecol 3:310–317

    Article  CAS  PubMed  Google Scholar 

  28. Gembruch U (1997) Prenatal diagnosis of congenital heart disease. Prenat Diagn 17:1283–1297

    Article  CAS  PubMed  Google Scholar 

  29. Gembruch U, Chaoui R (1997) Möglichkeiten und Grenzen eines Screeningprogrammes. Gynäkologe 30:191–199

    Google Scholar 

  30. Gembruch U, Smrcek J (1997) The prevalence and clinical significance of tricuspid valve regurgitation in normally grown fetuses and those with intrauterine growth retardation. Ultrasound Obstet Gynecol 9:1–9

    Article  PubMed  Google Scholar 

  31. Gembruch U, Shi C, Smrcek J (2000) Biometry of the fetal heart between 10 and 17 weeks of gestation. Fetal Diagn Ther 15:20–31

    Article  CAS  PubMed  Google Scholar 

  32. Gembruch U, Geipel A (2003) Indication for fetal echocardiography: screening in low- and high-risk populations. In: Yagel S, Silverman N, Gembruch U (eds) Fetal cardiology. Thomson Publishing Services, Andover, pp 89–106

  33. Gerlis L (1985) Cardiac malformations in spontaneous abortions. Int J Cardiol 7:29–46

    Article  CAS  PubMed  Google Scholar 

  34. Germer U, Baschat A, Gembruch U (1997) Frühe fetale Echokardiographie. Gynäkologe 30:200–209

    Google Scholar 

  35. Ghi T, Huggon I, Zosmer N, Nicolaides K (2001) Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol 18:610–614

    Article  CAS  PubMed  Google Scholar 

  36. Haak M, Twisk J, Van Vugt J (2002) How successful is fetal echocardiographic examination in the first trimester of pregnancy? Ultrasound Obstet Gynecol 20:9–13

    Article  CAS  PubMed  Google Scholar 

  37. Hoffman J, Christianson R (1978) Congenital heart disease in a cohort of 19.502 birth with longterm follow-up. Am J Cardiol 42:641–647

    Article  CAS  PubMed  Google Scholar 

  38. Hoffman J (1990) Congenital heart disease: incidence and inheritance. Pediatr Clin North Am 37:25–43

    CAS  PubMed  Google Scholar 

  39. Hoffman J (1994) Reflections on the past, present, and future of paediatric cardiology. Cardiol Young 4:208–223

    Google Scholar 

  40. Hyett J, Moscoso G, Papapanagiotou G et al. (1996) Abnormalities of the fetal heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11–13 weeks of gestation. Ultrasound Obstet Gynecol 7:245–250

    Article  CAS  PubMed  Google Scholar 

  41. Hyett J, Noble P, Snijders R et al. (1996) Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10–14 weeks of gestation. Ultrasound Obstet Gynecol 7:239–244

    Article  CAS  PubMed  Google Scholar 

  42. Hyett J, Perdu M, Sharland G et al. (1997) Increased nuchal translucency at 10–14 weeks of gestation as a marker for major cardiac defects. Ultrasound Obstet Gynecol 10:242–246

    Article  CAS  PubMed  Google Scholar 

  43. Hyett J, Perdu M, Sharland G et al. (1999) Using fetal nuchal translucency to screen for major cardiac defects at 10–14 weeks of gestation: population based cohort study. BMJ 318:81–85

    CAS  PubMed  Google Scholar 

  44. Koren G, Edward M, Miskin M (1987) Antenatal sonography of fetal malformations associated with drugs and chemicals: a guide. Am J Obstet Gynecol 156:79–85

    CAS  PubMed  Google Scholar 

  45. Lopes L, Brizot M, Lopes M et al. (2003) Structural and functional cardiac abnormalities identified prior to 16 weeks‘ gestation in fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 22:470–478

    Article  CAS  PubMed  Google Scholar 

  46. Matias A, Huggon I, Areias J et al. (1999) Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus flow at 10–14 weeks. Ultrasound Obstet Gynecol 14:307–310

    Article  CAS  PubMed  Google Scholar 

  47. Matsuoka R, Takao A, Kimura M et al. (1994) Confirmation that the conotruncal anomaly face syndrome is associated with a deletion within 22q11. Am J Med Genet 53:285–289

    CAS  PubMed  Google Scholar 

  48. Mavrides E, Cobian-Sanchez F, Tekay A et al. (2001) Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 17:106–110

    Article  CAS  PubMed  Google Scholar 

  49. Mennicke K, Schwinger E (1997) Genetische Aspekte kongenitaler fetaler Herzerkrankungen. Gynäkologe 30:181–189

    Google Scholar 

  50. Nicolaides K, Snijders R, Gosden C et al. (1992) Ultrasonographically detectable markers of fetal chromosomal abnormalities. Lancet 340:704–707

    Article  CAS  PubMed  Google Scholar 

  51. Nora J, Nora A (1988) Update on counselling the family with a first degree relative with a congenital heart defect. Am Med Genet 29:137–142

    CAS  Google Scholar 

  52. Nora J (1993) Causes of congenital heart diseases: old and new modes, mechanisms, and models. Am Heart J 125:1409–1419

    Article  CAS  PubMed  Google Scholar 

  53. Pandya P, Kondylios A, Hilbert L et al. (1995) Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 5:15–19

    Article  CAS  PubMed  Google Scholar 

  54. Payne R, Johnson M, Grant J, Strauss A (1995) Toward a molecular understanding of congenital heart disease. Circulation 91:494–504

    CAS  PubMed  Google Scholar 

  55. Porat S, Anteby E, Hamani Y, Yagel S (2003) Fetal supraventricular tachycardia diagnosed and treated at 13 weeks of gestation: a case report. Ultrasound Obstet Gynecol 21:302–305

    Article  CAS  PubMed  Google Scholar 

  56. Rustico M, Benettoni A, D’Ottavio G et al. (2000) Early screening for fetal cardiac anomalies by transvaginal echocardiography in an unselected population: the role of operator experience. Ultrasound Obstet Gynecol 16:614–619

    Article  CAS  PubMed  Google Scholar 

  57. Schwärzler P, Carvalho J, Senat M et al. (1999) Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10–14 weeks of gestation as part of routine antenatal care in an unselected population. J Obstet Gynecol 106:1029–1034

    Google Scholar 

  58. Shapiro I, Degani S, Leobovitz Z et al. (1998) Fetal cardiac measurements derived by transvaginal and transabdominal cross-sectional echocardiography from 14 weeks of gestation to term. Ultrasound Obstet Gynecol 12:404–418

    Article  CAS  PubMed  Google Scholar 

  59. Smrcek J, Germer U, Gembruch U (1998) Functional pulmonary valve regurgitation in the fetus. Ultrasound Obstet Gynecol 12:254–259

    Article  CAS  PubMed  Google Scholar 

  60. Smrcek J, Gembruch U (1999) Longitudinal observations in normally grown fetuses with tricuspid valve regurgitation: report of 22 cases. Prenat Diagn 19:197–204

    Article  CAS  PubMed  Google Scholar 

  61. Smrcek J, Gembruch U, Krokowski M et al. (2003) The evaluation of cardiac biometry in major cardiac defects detected in early pregnancy. Arch Gynecol Obstet 268:94–101

    CAS  PubMed  Google Scholar 

  62. Souka A, Snijders R, Novakow A et al. (1998) Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency at 10–14 weeks of gestation. Ultrasound Obstet Gynecol 11:391–400

    Article  CAS  PubMed  Google Scholar 

  63. Souka A, Krampl E, Bakalis S et al. (2001) Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 18:9–17

    Article  CAS  PubMed  Google Scholar 

  64. Tworetzki W, McElhinnery D, Reddy V et al. (2001) Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation 103:1269–1273

    PubMed  Google Scholar 

  65. Ursell P, Byrne J, Strobino B (1985) Significance of cardiac defects in the developing fetus: a study of spontaneous abortuses. Circulation 72:1232–1236

    CAS  PubMed  Google Scholar 

  66. Verheijen P, Lisowski L, Stoutenbeek P (2001) Prenatal diagnosis of congenital heart disease affects preoperative acidosis in the newborn patient. J Thorac Cardiovasc Surg 121:798–803

    Article  CAS  PubMed  Google Scholar 

  67. Wisser J, Dirschedl P (1994) Embryonic heart rate in dated human embryos. Early Hum Dev 37:107–115

    Article  CAS  PubMed  Google Scholar 

  68. Yagel S, Weismann A, Rotstein Z et al. (1997) Congenital heart defects: natural course and in utero development. Circulation 96:550–555

    CAS  PubMed  Google Scholar 

  69. Yagel S, Cohen S, Achiron R (2001) Examination of the fetal heart by five short-axis views: a proposed screening method for comprehensive cardiac evaluation. Ultrasound Obstet Gynecol 17:367–369

    Article  CAS  PubMed  Google Scholar 

  70. Yoo S, Lee Y, Kim E (1997) Three-vessel view of the fetal upper mediastinum: an easy means of detecting abnormalities of the ventricular outflow tracts and great arteries during obstetric screening. Ultrasound Obstet Gynecol 9:173–182

    Article  CAS  PubMed  Google Scholar 

  71. Yoo S, Young H, Kyoung S (1999) Abnormal three-vessel view on sonography: a clue to the diagnosis of congenital heart disease in the fetus. Am J Roentgenol 172:825–830

    CAS  Google Scholar 

  72. Zerres K, Gembruch U, Schwanitz G et al. (1990) Fetale Echokardiographie und klinische Genetik—eine enge Wechselbeziehung. Z Kardiol 79:96–106

    CAS  PubMed  Google Scholar 

  73. Zosmer N, Souter V, Chan C et al. (1999) Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency. Br J Obstet Gynecol 106:829–833

    CAS  Google Scholar 

Download references

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Smrcek.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smrcek, J., Krapp, M., Axt-Fliedner, R. et al. Frühe fetale Echokardiographie. Gynäkologe 37, 716–724 (2004). https://doi.org/10.1007/s00129-004-1568-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00129-004-1568-x

Schlüsselwörter

Keywords

Navigation